-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Closing Remarks

Symposia: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies Program: Scientific Workshops
Friday, December 8, 2023: 4:59 PM-5:00 PM
Room 7 (San Diego Convention Center)
and Daniel T. Starczynowski, PhD, University of Cincinnati
Starczynowski: Sumitomo Pharma Oncology: Research Funding; Captor Therapeutics: Consultancy; Kurome Therapeutics: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties, Research Funding; Treeline Biosciences: Research Funding; Tolero Therapeutics: Research Funding; Kymera Therapeutics: Consultancy.